Though some findings were reassuring, others do raise concerns. Specifically, three of the studies—one from Sweden, another from France, and a third that combined data from 13 countries—suggest a connection between heavy cell-phone use and gliomas, tumors that are usually cancerous and often deadly. One of those studies also hinted at a link between cell phones and acoustic neuromas (noncancerous tumors), and two studies hinted at meningiomas, a relatively common but usually not deadly brain tumor.
The U.S. Food and Drug Administration (FDA) notes that studies reporting biological changes associated with radiofrequency radiation have failed to be replicated and that the majority of human epidemiologic studies have failed to show a relationship between exposure to radiofrequency radiation from cell phones and health problems. The FDA, which originally nominated this exposure for review by the NTP in 1999, issued a statement on the draft NTP reports released in February 2018, saying “based on this current information, we believe the current safety limits for cell phones are acceptable for protecting the public health.” FDA and the Federal Communications Commission share responsibility for regulating cell phone technologies.
"Partner Content" allows today's industry thought leaders to share their unique insight and perspective with the greater ASPENCORE audience. Material published as "Partner Content" was created by or on behalf of ASPENCORE's partner(s) in conjunction with the ASPENCORE Studio team and may not reflect the views of the site and editors to which it is published.For more information on this program, email firstname.lastname@example.org
Over time, the number of cell phone calls per day, the length of each call, and the amount of time people use cell phones have increased. Because of changes in cell phone technology and increases in the number of base stations for transmitting wireless signals, the exposure from cell phone use—power output—has changed, mostly lowered, in many regions of the United States (1).